Hales Life Science and Technology Laboratory (Hebei) project landed in Gu'an Tiangu Biomedical Industrial Park, and is preparing to build a GMP standard Modernized the establishment of cell laboratories and cell experiment raw material production bases, equipped with ten 100-level life science and technology laboratories, including five self-owned technology transformation 100-level laboratories, and five public platforms using 100-level laboratories, aiming to cultivate biological Young talent in tech.  

Laboratory composition: cell preparation laboratory, cell storage center, intercellular storage room, skin cell culture room, Preparation room and observation room.  

On September 29, 2021, Gu'an County held the third quarter investment promotion project centralized signing event with the people of Gu'an County The government held a signing ceremony and held a press conference.

Halls Innovative Drug R&D and Achievement Transformation Center's main cooperative co-constructor - China Pharmaceutical University 

China Pharmaceutical University, founded in 1936, is the first institution of higher learning of pharmacy established by the state in the history of my country. The school is a university directly under the Ministry of Education, the national "211 Project" and "985 Project Advantage Discipline Innovation Platform". It is a multidisciplinary and research-oriented university featuring pharmacy, among which pharmacy and Chinese pharmacy are the leading disciplines of pharmacy. Group Construction has always maintained a leading domestic level and is known as the "Cradle of Chinese Biomedical Talents". In 2017, it became a national "double first-class" construction university. In the 2022 US News World University Rankings, the subject of pharmacology and toxicology ranks 13th in the world and 1st in Asia. In the subject ranking of the Center for World University Rankings (CWUR), the subject of medicinal chemistry ranks third in the world. In the 2021 ranking of the best disciplines in China, the disciplines of pharmacy and Chinese pharmacy ranked first and second in China, and both entered the "Top Disciplines in China".  

Hales Innovative Drug Research and Development and Achievement Transformation Center (hereinafter referred to as Haers Innovation and Research Center) Haners Innovation and Research Center is an innovative drug R&D platform and pharmaceutical R&D contract outsourcing service organization (CRO) jointly established by Haners Pharmaceutical (Hebei) Co., Ltd. and China Pharmaceutical University. It provides public testing and product development for major corporate projects. Serve. Haners Innovation and Research Center has sustainable sources of knowledge and technology and a rich resource base. It is a new technology platform with large-scale equipment, integrated service functions, and systematic technical capabilities.

Independent innovative drug development: depression, osteoporosis, diabetes, organic lithium, organic strontium, barberry tartrate Alkali etc.  

Pharmaceutical R&D Contract Outsourcing Services:The final implementation of any technological invention requires a system to solve the problem of multiple technical collaborations and meet practical applications. The Hans Innovation and Research Center is open and shared for innovative drugs in vitro diagnosis, biological materials and smart medical care, and provides task-oriented one-stop technical services for high-level research activities and achievement transformation for a long time. Through the rapid verification of new products and the adoption of a typical model of international technology transfer and transformation, the rapid transformation of basic research results of biopharmaceuticals into clinical application and industrialization.  

Open system: large-scale instruments and equipment, professional technical services, user-shared laboratories, open research programs and cooperation. For pharmaceutical companies, cooperation with the Hans Innovation and Research Center can significantly reduce capital investment and shorten the industrialization cycle for the transformation and industrialization of the company's achievements, and can shorten the transformation cycle of biopharmaceutical research results from the current 10 to 15 years. to 5 to 8 years.  

Before large, expensive and lengthy clinical trials, new technology from the Hales Institute allows us to predict potential whether treatments will work. In the later stage of development, if the data after the product is put into the market and predictions made in the early stage, it will greatly promote the development of the therapeutic field. The research and development goals and unique innovation perspective of the Hans Innovation and Research Center will lead the market in the 100 billion level.